Growing S'pore medtech industry eyes region
Manufacturing output more than doubles in a decade
[SINGAPORE] From next year, a trip to your optician could end up saving your eyesight.
That is, if local start-up Algo Access has anything to say about it. In December last year, the firm bought licensing rights to one of the projects under the Agency for Science, Technology and Research's (A*Star) Biomedical Engineering Programme (BEP).
Dubbed the automatic glaucoma diagnosis and its genetic association study through medical image informatics (AGLAIA) project, the tool is used to screen for glaucoma - an eye disease that can result in blindness in advanced cases - and age-related macular degeneration (AMD). Algo Access eventually hopes to use the tool to screen for diabetes as well.
The image processing software scans and analyses a shot of a patient's retina, which can be taken at the optician's using a Fundus camera, in about…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
New Articles
Digital Core Reit Q1 distributable income slips 2.4% to US$10.6 million
BT subscribers can now share 5 premium articles a month with unlimited number of non-subscribers
First Reit reports 3.2% lower Q1 DPU of S$0.006 amid interest rate, forex headwinds
Vietnam holds first gold auction in 11 years to stabilise market
How Hudson Yards went from ghost town to office success story
Hot stock: Nanofilm jumps 13.1% amid heavy trading on improved Q1 results